AstraZeneca has opened its first U.S.-operated cell therapy manufacturing facility in Rockville, Maryland, as part of its ...

The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...

The British pharma giant's expansion in Montgomery County comes at a crucial time for the local biotech sector. New Md. hospital could break ground next year — with ...

AstraZeneca is bolstering its US manufacturing presence as President Donald Trump's White Hulls mulls the imposition of fresh ...

AstraZeneca opened a $300M CAR-T cell therapy facility in Rockville, boosting Maryland's life sciences sector and creating ...

AstraZeneca, as part of its ongoing $3.5 billion ... The U.K-based pharmaceutical giant said the new $300 million plant in Rockville symbolizes its confidence in America’s role as a "global ...

ROCKVILLE, Md. (DC News Now) — AstraZeneca has opened a new $300 million cell therapy manufacturing facility in Rockville, marking the company’s first fully owned site of its kind globally.